SCPH — SCPHARMACEUTICALS INC

Ownership history in PERCEPTIVE ADVISORS LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which PERCEPTIVE ADVISORS LLC reported a position in SCPHARMACEUTICALS INC (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.19% (2022 Q4)
Avg. % of fund
0.09%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 583,142 +83,142 +16.6% 0.10% $3.3M —
2025 Q2 UNCHANGED 500,000 — 0% 0.07% $1.9M —
2025 Q1 UNCHANGED 500,000 — 0% 0.05% $1.3M —
2024 Q4 REDUCED 500,000 -452,380 -47.5% 0.05% $1.8M —
2022 Q4 INITIATED 952,380 — — 0.19% $6.8M —
% of Fund (quarterly)

Other funds also holding SCPH

As of 2025 Q3 — sorted by position size

Yakira Capital Management, Inc. 3Y 7Y 0.87% ORBIMED ADVISORS LLC 3Y 7Y 0.81% Tejara Capital Ltd 3Y 0.73% Newtyn Management, LLC 3Y 7Y 0.65% APIS CAPITAL ADVISORS, LLC 3Y 7Y 0.55% Rangeley Capital, LLC 0.46% Balanced Rock Investment Advisors LLC 0.34% ALPINE ASSOCIATES MANAGEMENT INC. 3Y 7Y 0.33% Rubric Capital Management LP 3Y 7Y 0.33% GABELLI & Co INVESTMENT ADVISERS, INC. 3Y 7Y 0.28%
← Back to PERCEPTIVE ADVISORS LLC Holdings